Cargando…
Therapeutic effect of an anti-human-TNF-alpha antibody and itraconazole on feline infectious peritonitis
Feline infectious peritonitis (FIP) is a fatal disease in wild and domestic cat species. Although several drugs are expected to be useful as treatments for FIP, no drugs are available in clinical practice. In this study, we evaluated the therapeutic effect of combined use of adalimumab (an anti-huma...
Autores principales: | Doki, Tomoyoshi, Toda, Masahiro, Hasegawa, Nobuhisa, Hohdatsu, Tsutomu, Takano, Tomomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110289/ https://www.ncbi.nlm.nih.gov/pubmed/32236683 http://dx.doi.org/10.1007/s00705-020-04605-7 |
Ejemplares similares
-
Therapeutic effect of anti-feline TNF-alpha monoclonal antibody for feline infectious peritonitis
por: Doki, Tomoyoshi, et al.
Publicado: (2016) -
Generation, characterization and therapeutic potential of anti-feline TNF-alpha MAbs for feline infectious peritonitis
por: Doki, Tomoyoshi, et al.
Publicado: (2013) -
In vitro antiviral effects of GS-441524 and itraconazole combination against feline infectious peritonitis virus
por: Doki, Tomoyoshi, et al.
Publicado: (2022) -
Antiviral activity of itraconazole against type I feline coronavirus infection
por: Takano, Tomomi, et al.
Publicado: (2019) -
Development of a mouse-feline chimeric antibody against feline tumor necrosis
factor-alpha
por: DOKI, Tomoyoshi, et al.
Publicado: (2016)